immunitoAI
Type
Startup
Founded
2020
Funding captured
$6.1m
Deals captured
1
About immunitoAI
immunitoAI is a biotechnology-focused startup that applies computational methods and machine learning to immunology and antibody discovery. The company develops AI-driven platforms and workflows to design, optimise, and prioritise therapeutic antibodies and biologics, supporting preclinical research and translational development. Its core activities include in-silico candidate generation, predictive modelling of immune responses, and enabling partner research teams to accelerate biologics discovery and reduce experimental cycles.
immunitoAI funding captured (1)
| Deal type | Stage | Date | Amount | Investors |
|---|---|---|---|---|
| Equity | Undisclosed | Nov 25, 2025 | $6.1m |